Company intelligence / Profile preview

Axis Insight

San Diego, California, United Statesaxis.cpm-int.com ↗

Ownership: Private
Development stage: Other

Overview

AxisPharm is a global CRO/CDMO specializing in bioconjugation technologies. It provides high-purity PEG linkers, ADC linkers, fluorescent probes, lipid molecules for drug delivery optimization, as well as analytical services such as mass spectrometry and HPLC. The company supports preclinical research with custom synthesis capabilities but does not appear to have its own therapeutic pipeline or clinical trial results.

Modalities: Small moleculePeptidesPolymer-drug conjugate therapyAntibody-drug conjugateBiologic
Industry: Contract Manufacturing Organization

Partnerships

Hikma PharmaceuticalsTexas A&M University

Beyond the preview

Go deeper on Axis Insight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axis Insight.

Explore the full profile